Evidence map›Paper›PMID 38875546›Full record

ArticleJMIR AI2023

Predicting Treatment Interruption Among People Living With HIV in Nigeria: Machine Learning Approach.

Matthew-David Ogbechie, Christa Fischer Walker, Mu-Tien Lee, Amina Abba Gana, Abimbola Oduola, Augustine Idemudia, Matthew Edor, Emily Lark Harris, Jessica Stephens, Xiaoming Gao and 2 more

Abstract read
In one paragraph

Article in JMIR AI, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Matthew-David Ogbechie *FHI 360, Abuja, Nigeria.ORCID https://orcid.org/0009-0007-3962-4100
Christa Fischer Walker *FHI 360, Washington, DC, United States.ORCID https://orcid.org/0000-0003-3367-6456
Mu-Tien LeeFHI 360, Durham, NC, United States.ORCID https://orcid.org/0009-0001-8855-5769
Amina Abba GanaFHI 360, Abuja, Nigeria.ORCID https://orcid.org/0009-0000-0667-1911
Abimbola OduolaFHI 360, Abuja, Nigeria.ORCID https://orcid.org/0000-0002-2234-2912
Augustine IdemudiaFHI 360, Abuja, Nigeria.ORCID https://orcid.org/0000-0002-2193-6401
Matthew EdorFHI 360, Abuja, Nigeria.ORCID https://orcid.org/0009-0000-8552-3502
Emily Lark HarrisUnited States Agency for International Development, Dar es Salaam, United Republic of Tanzania.ORCID https://orcid.org/0009-0003-1613-8549
Jessica StephensUnited States Agency for International Development, Washington, DC, United States.ORCID https://orcid.org/0000-0001-5166-8420
Xiaoming GaoFHI 360, Durham, NC, United States.ORCID https://orcid.org/0000-0002-6058-8120
Pai-Lien ChenFHI 360, Durham, NC, United States.ORCID https://orcid.org/0000-0001-8910-5316
Navindra Etwaroo Persaud *FHI 360, Washington, DC, United States.ORCID https://orcid.org/0000-0002-7694-4505

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAntiretroviral therapy (ART) has transformed HIV from a fatal illness to a chronic disease. Given the high rate of treatment interruptions, HIV programs use a range of approaches to support individuals in adhering to ART and in re-engaging those who interrupt treatment. These interventions can often be time-consuming and costly, and thus providing for all may not be sustainable.

objectiveThis study aims to describe our experiences developing a machine learning (ML) model to predict interruption in treatment (IIT) at 30 days among people living with HIV newly enrolled on ART in Nigeria and our integration of the model into the routine information system. In addition, we collected health workers' perceptions and use of the model's outputs for case management.

methodsRoutine program data collected from January 2005 through February 2021 was used to train and test an ML model (boosting tree and Extreme Gradient Boosting) to predict future IIT. Data were randomly sampled using an 80/20 split into training and test data sets, respectively. Model performance was estimated using sensitivity, specificity, and positive and negative predictive values. Variables considered to be highly associated with treatment interruption were preselected by a group of HIV prevention researchers, program experts, and biostatisticians for inclusion in the model. Individuals were defined as having IIT if they were provided a 30-day supply of antiretrovirals but did not return for a refill within 28 days of their scheduled follow-up visit date. Outputs from the ML model were shared weekly with health care workers at selected facilities.

resultsAfter data cleaning, complete data for 136,747 clients were used for the analysis. The percentage of IIT cases decreased from 58.6% (36,663/61,864) before 2017 to 14.2% (3690/28,046) from October 2019 through February 2021. Overall IIT was higher among clients who were sicker at enrollment. Other factors that were significantly associated with IIT included pregnancy and breastfeeding status and facility characteristics (location, service level, and service type). Several models were initially developed; the selected model had a sensitivity of 81%, specificity of 88%, positive predictive value of 83%, and negative predictive value of 87%, and was successfully integrated into the national electronic medical records database. During field-testing, the majority of users reported that an IIT prediction tool could lead to proactive steps for preventing IIT and improving patient outcomes.

conclusionsHigh-performing ML models to identify patients with HIV at risk of IIT can be developed using routinely collected service delivery data and integrated into routine health management information systems. Machine learning can improve the targeting of interventions through differentiated models of care before patients interrupt treatment, resulting in increased cost-effectiveness and improved patient outcomes.

Indexed as

antiretroviral therapychronic diseasedata collectionHIVHIV programinterventionmachine learningNigeriatreatment interruption

Identifiers

PMID38875546
PMCPMC11041440

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.